Abstract
In recent years, the functional importance of the anterior temporal lobes (ATLs) has come to prominence in two active, albeit unconnected branches of the literature. In one branch, neuropsychology and functional neuroimaging evidence emphasises the role of the ATLs in face recognition and linking faces to biographical knowledge. In the other, cognitive and clinical neuroscience investigations have shown that the ATLs are critical to all forms of semantic memory. To draw these literatures together and generate a unified account of ATL function, we test the predictions arising from each literature and examine the effects of bilateral versus unilateral ATL damage on face recognition, person knowledge and semantic memory. Sixteen people with bilateral ATL atrophy from semantic dementia (SD), 17 people with unilateral ATL resection for temporal lobe epilepsy (TLE; left=10, right=7), and 14 controls completed a test battery encompassing general semantic processing, person knowledge and perceptual face matching. SD patients were severely impaired across all semantic tasks, including person knowledge. Despite commensurate total ATL damage, unilateral resection generated mild impairments, with minimal differences between left- and right-ATL resection. Face matching performance was largely preserved but slightly reduced in SD and right TLE. All groups displayed the classic familiarity effect in face matching; however, this benefit was reduced in SD and right TLE groups and was aligned with the level of item-specific semantic knowledge in all participants. We propose a unified neurocognitive framework whereby the ATLs underpin a resilient bilateral representation system that supports semantic memory, person knowledge and face recognition.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
M.A.R is supported by the Medical Research Council (SUAG/096 G116768). A.D.H is supported by the Medical Research Council (Career Development Award: MR/V031481/1). A.V was supported by the Universite de Lorraine for this project (DrEAM/LUE grant). J.B.R is supported by the Medical Research Council (MC_UU_00030/14; MR/T033371,1), Wellcome Trust (220258), and the NIHR Cambridge Biomedical Research Centre (NIHR203312). M.A.L.R is supported by a Medical Research Council programme grant (MR/R023883/1) and intramural funding (MC_UU_00005/18). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Research Ethics Service's East of England Cambridge Central Committee gave ethical approval for this work(IRAS project ID: 252986)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Due to the limits of the ethics approval for these patient studies, the data cannot be openly shared. Requests for suitably anonymised data can be addressed to the senior author and may require a data transfer agreement.
